Literature DB >> 4210440

[Juvenile GM2 gangliosidosis with altered substrate specificity of hexosaminidase A (author's transl)].

J Zerfowski, K Sandhoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4210440     DOI： 10.1007/bf00687632

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  20 in total

1.  The hydrolysis of Tay-Sachs ganglioside (TSG) by human N-acetyl-beta-D-hexosaminidase A.

Authors:  K Sandhoff
Journal:  FEBS Lett       Date:  1970-12-18       Impact factor: 4.124

2.  Variation of beta-N-acetylhexosaminidase-pattern in Tay-Sachs disease.

Authors:  K Sandhoff
Journal:  FEBS Lett       Date:  1969-08       Impact factor: 4.124

3.  Age-dependent variations of the human N-acetyl- -D-hexosaminidases.

Authors:  K Harzer; K Sandhoff
Journal:  J Neurochem       Date:  1971-11       Impact factor: 5.372

4.  Gm2-gangliosidosis with total hexosaminidase deficiency.

Authors:  Y Suzuki; J C Jacob; K Suzuki; K M Kutty; K Suzuki
Journal:  Neurology       Date:  1971-04       Impact factor: 9.910

5.  Generalized accumulation of neutral glycosphingolipids with GM2 ganglioside accumulation in the brain. Sandhoff's disease (variant of Tay-Sachs disease).

Authors:  W Krivit; R J Desnick; J Lee; J Moller; F Wright; C C Sweeley; P D Snyder; H L Sharp
Journal:  Am J Med       Date:  1972-06       Impact factor: 4.965

6.  [On the behavior of brain gangliosides in 2 cases of late infantile amaurotic idiocy].

Authors:  H Bernheimer; F Seitelberger
Journal:  Wien Klin Wochenschr       Date:  1968-03-01       Impact factor: 1.704

7.  [Resolution of mammalian N-acetyl-beta-D-hexosaminidase into multiple forms by electrofocussing].

Authors:  K Sandhoff
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1968-09

8.  Identification of Tay-Sachs disease carriers by acrylamide gel electrophoresis.

Authors:  J Friedland; L Schneck; A Saifer; M Pourfar; B W Volk
Journal:  Clin Chim Acta       Date:  1970-06       Impact factor: 3.786

9.  Partial deficiency of hexosaminidase component a in juvenile gm2-gangliosidosis.

Authors:  Y Suzuki; K Suzuki
Journal:  Neurology       Date:  1970-09       Impact factor: 9.910

10.  Generalized accumulation of neutral glycosphingolipids with G M2 ganglioside accumulation in the brain.

Authors:  P D Snyder; W Krivit; C C Sweeley
Journal:  J Lipid Res       Date:  1972-01       Impact factor: 5.922
View more
  6 in total

Review 1.  Biochemistry and genetics of gangliosidoses.

Authors:  K Sandhoff; H Christomanou
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  [Sphingolipid storage disease as an example of a molecular neuropathology (author's transl)].

Authors:  H Jatzkewitz; K Sandhoff
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1976-04-30

3.  Sphingolipidoses.

Authors:  K Sandhoff
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

4.  GM2-gangliosidosis, AB variant: clinico-pathological study of a case.

Authors:  C M de Baecque; K Suzuki; I Rapin; A B Johnson; D L Whethers
Journal:  Acta Neuropathol       Date:  1975-12-19       Impact factor: 17.088

5.  Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level.

Authors:  E Conzelmann; H J Kytzia; R Navon; K Sandhoff
Journal:  Am J Hum Genet       Date:  1983-09       Impact factor: 11.025

6.  Alpha-locus hexosaminidase genetic compound with juvenile gangliosidosis phenotype: clinical, genetic, and biochemical studies.

Authors:  W G Johnson; C S Cohen; A F Miranda; S P Waran; A M Chutorian
Journal:  Am J Hum Genet       Date:  1980-07       Impact factor: 11.025
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.